BSTI, feedback? Small float, could be fun?|
BioShield is expected to spin off eMD.com this year in a separate IPO.
Similar medical IPOs have been valued in excess of 1 BILLION dollars.
eMD.com is the LEADING site in its field and the IPO should result in
1-1.5 BILLION! With a float of only 3.2 Million this should send the
price into the hundreds this year!
BioShield's eMD.com Surpasses 100 Million Lives Insured Under Third-Party
Contracts; Largest of Business-to-Business e-Health Companies
February 23, 2000 07:32 AM
ATLANTA, Feb. 23 /PRNewswire/ -- eMD.com(TM), a business-to-business
Internet healthcare subsidiary of BioShield(TM) Technologies, Inc. BSTI
has signed contracts with 42 managed care organizations and pharmacy
benefits management companies, representing more than 100 million patients
across the United States.
No other e-healthcare company in eMD.com's category has secured agreements
covering more Americans.
"Securing third-party contracts enables us to deliver helpful
pharmaceutical care services to patients covered under these medical and
prescription benefits plans," said Kevin F. Smith, M.D., chief medical
officer, eMD.com. "Patients, their physicians and insurance payors can
take full advantage of eMD.com's point-of-care medication management and
Accessible from a physician's office through www.emd.com, the password-
protected application includes electronic prescribing, online medical
charting, drug fulfillment and pharmaceutical care services such as
monitoring chronic disease patients for prescription compliance. It is
partly designed to perform as a risk management tool, helping the
healthcare industry reduce medical errors.
The company's medication management and charting software is available to
physicians free of charge. eMD.com tailors the open platform to physician
practices of all sizes, including those linked with larger independent
physician associations (IPA). As an application service provider, eMD.com
offers the system to managed care (MCO), health maintenance (HMO) and
preferred provider (PPO) organizations, as well as to pharmacy benefits
management (PBM) groups.
eMD.com integrates its medication management and charting system with a
host of pharmaceutical care services and a chronic disease focused
consumer website, found at www.emd.com .
www.emd.com provides consumers with in-depth Health Centers, daily medical
news and a variety of services, including: free 24/7 access to a team of
online medical experts to answer questions; safe and convenient
prescription re-fulfillment; online discussions to share similar health
concerns and experiences; helpful tips to create an environmentally
friendly Healthy Home; and an online store to purchase OTC medications,
nutraceuticals and other healthcare products. The website soon will give
patients secured access to their password-protected medical charts,
including prescription history.
eMD.com is a chronic disease focused e-healthcare subsidiary of Atlanta-
based BioShield Technologies, Inc. eMD.com primarily is a business-to-
business Internet healthcare company dedicated to point-of-care medication
management that improves physician NCQA compliance and patient outcomes.
The company's vision is to be recognized as a leading provider of
Web-based technology solutions for physicians, complemented by a preferred
Internet location for consumer healthcare information and e-commerce. More
information can be found at www.emd.com and www.bioshield.com or by
Safe Harbor/Forward-Looking Statements
Statements in this news release that are not historical are
forward-looking statements and are intended to fall within the Safe Harbor
provisions of the federal securities laws. These forward-looking
statements are subject to certain risks and uncertainties that could cause
actual results to differ materially from those anticipated in any
forward-looking statements, all of which are difficult to predict and many
of which are beyond the control of the company, including areas such as:
developing technologies; dependence on collaborative partners; the
inherent complexity and uncertainty regarding the development of products;
early-stage development of BioShield and eMD.com; the result of research
and development efforts; future capital needs; uncertainty of additional
funding; government regulations; and other factors which are detailed in
the company's periodic reports and registration statements filed with the
Securities and Exchange Commission. BioShield does not undertake to revise
or update any forward-looking statement to reflect events or circumstances
that may arise after the date hereof.
eMD.com is a trademark of Electronic Medical Distribution, Inc., a
subsidiary of BioShield Technologies, Inc. BioShield is a trademark of
BioShield Technologies, Inc.
SOURCE BioShield Technologies, Inc.